糖尿病性神经病变：定义、诊断标准、严重程度评估和治疗的更新。
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.
机构信息
Diabetes Research Unit, Sheffield Teaching Hospitals, Sheffield, UK.
出版信息
Diabetes Care. 2010 Oct;33(10):2285-93. doi: 10.2337/dc10-1303.
Abstract
Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13-18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.
摘要
在第 19 届欧洲糖尿病研究协会（EASD）糖尿病神经病变研究组年会和第 8 届加拿大多伦多国际糖尿病神经病变研讨会召开之前，于 2009 年 10 月 13 日至 18 日召集了专家小组，提供糖尿病周围神经病变（DPN）、自主神经病变、痛性 DPN 和 DPN 结构改变的分类、定义、诊断标准和治疗的最新信息。
相似文献
1
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.糖尿病性神经病变：定义、诊断标准、严重程度评估和治疗的更新。
Diabetes Care. 2010 Oct;33(10):2285-93. doi: 10.2337/dc10-1303.
2
Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity.糖尿病性多发性神经病：研究定义、诊断标准和严重程度评估的更新。
Diabetes Metab Res Rev. 2011 Oct;27(7):620-8. doi: 10.1002/dmrr.1226.
3
[Diabetes mellitus and autoimmune neuropathy].[糖尿病与自身免疫性神经病]
Brain Nerve. 2014 Feb;66(2):135-47.
4
International Neuropathy Workshop of 2009: introduction to the final reports.2009 年国际神经病学研讨会：最终报告简介。
Diabetes Metab Res Rev. 2011 Oct;27(7):617-9. doi: 10.1002/dmrr.1228.
5
6
6th Diabetic Neuropathy Satellite Symposium of the 18th International Diabetes Federation Congress in conjunction with 13th Annual Meeting of the Diabetic Neuropathy Study Group of the EASD (NEURODIAB XIII). Saint Malo, France, 30 August-2 September 2003. Abstracts.第18届国际糖尿病联盟大会第六届糖尿病神经病变卫星研讨会，联合欧洲糖尿病研究协会糖尿病神经病变研究组第13届年会（神经糖尿病学第十三届会议）。2003年8月30日至9月2日于法国圣马洛。摘要。
J Peripher Nerv Syst. 2003 Sep;8(3):169-203. doi: 10.1046/j.1529-8027.2003.03024.x.
7
Diabetic neuropathy.糖尿病性神经病。
Endocrinol Metab Clin North Am. 2013 Dec;42(4):747-87. doi: 10.1016/j.ecl.2013.06.001.
8
Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy.糖尿病性周围神经病变的诊断及门诊管理指南
Diabet Med. 1998 Jun;15(6):508-14. doi: 10.1002/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO;2-L.
9
PL37: a new hope in the treatment of painful diabetic neuropathy?PL37：治疗疼痛性糖尿病神经病变的新希望？
Pain Manag. 2016 Apr;6(2):129-32. doi: 10.2217/pmt.15.68. Epub 2016 Mar 17.
10
Report on the conjoint meetings of the Diabetic Neuropathy Study Group of the EASD (NEURODIAB) VII and the 4th Diabetic Neuropathy IDF satellite meeting held in Noordwijkerhout, The Netherlands, July 15-19, 1997.关于欧洲糖尿病研究学会糖尿病神经病变研究组（NEURODIAB）第七次联合会议以及第四届国际糖尿病联盟糖尿病神经病变卫星会议的报告，会议于1997年7月15日至19日在荷兰诺德韦克豪特举行。
Diabetologia. 1997 Dec;40(12):suppl 46-8.
引用本文的文献
1
Review of nonpharmacological interventions for delaying the effects of cerebral neuropathy caused by diabetes.延缓糖尿病所致脑神经病变影响的非药物干预措施综述
Front Endocrinol (Lausanne). 2025 Aug 27;16:1621448. doi: 10.3389/fendo.2025.1621448. eCollection 2025.
2
Combined minimally invasive vagal cranial nerve and trigeminocervical complex peripheral nerve stimulation produces prolonged improvement of severe painful peripheral neuropathy and hyperglycemia in type 2 diabetes.联合微创迷走神经和三叉神经颈复合体周围神经刺激可使2型糖尿病严重疼痛性周围神经病变和高血糖症得到长期改善。
Front Neurosci. 2025 Aug 26;19:1644961. doi: 10.3389/fnins.2025.1644961. eCollection 2025.
3
Machine Learning to Diagnose Complications of Diabetes.用于诊断糖尿病并发症的机器学习
J Diabetes Sci Technol. 2025 Sep 11:19322968251365245. doi: 10.1177/19322968251365245.
4
Sex Differences in Cardiovascular Risk and Diabetic Polyneuropathy: A Single-Center Retrospective Study in North-Eastern Hungary.心血管风险与糖尿病性多发性神经病变中的性别差异：匈牙利东北部的一项单中心回顾性研究
J Clin Med. 2025 Aug 15;14(16):5780. doi: 10.3390/jcm14165780.
5
Feasibility and priority strategies for diabetes prevention and control in Chinese demonstration areas.中国示范区糖尿病预防与控制的可行性及优先策略
Glob Health Action. 2025 Dec;18(1):2543605. doi: 10.1080/16549716.2025.2543605. Epub 2025 Aug 20.
6
Comparative performance of deep learning architectures for diabetic peripheral neuropathy detection using corneal confocal microscopy: a retrospective single-centre study.使用角膜共聚焦显微镜检测糖尿病周围神经病变的深度学习架构的比较性能：一项回顾性单中心研究。
BMJ Open. 2025 Aug 19;15(8):e095342. doi: 10.1136/bmjopen-2024-095342.
7
Influence of Genomic Ancestry and Other Traditional Risk Factors on the Prevalence of Diabetic Peripheral Neuropathy in Admixed Individuals With Type 1 Diabetes in Brazil: A Pioneer Multicenter Study.基因组血统和其他传统风险因素对巴西1型糖尿病混合个体中糖尿病周围神经病变患病率的影响：一项开创性的多中心研究。
J Peripher Nerv Syst. 2025 Sep;30(3):e70049. doi: 10.1111/jns.70049.
8
Cohort profile of the Heidelberg study on diabetes and complications HEIST-DiC.海德堡糖尿病与并发症研究（HEIST-DiC）的队列概况
Sci Rep. 2025 Aug 12;15(1):29580. doi: 10.1038/s41598-025-15343-8.
9
Blood Cell Count-Based Inflammatory Markers Exhibit Superior Association with Diabetic Peripheral Neuropathy Compared to Protein-Based Markers.与基于蛋白质的标志物相比，基于血细胞计数的炎症标志物与糖尿病周围神经病变的关联更为显著。
J Inflamm Res. 2025 Aug 7;18:10609-10617. doi: 10.2147/JIR.S524220. eCollection 2025.
10
Glycaemic control, low levels of high-density lipoprotein, and high cardiovascular risk are associated with cardiovascular autonomic neuropathy.血糖控制不佳、高密度脂蛋白水平低以及心血管风险高与心血管自主神经病变相关。
Diabetol Metab Syndr. 2025 Aug 4;17(1):313. doi: 10.1186/s13098-025-01834-1.
本文引用的文献
1
Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial.症状与体征与神经传导研究诊断糖尿病感觉运动性多神经病：Cl 与 NPhys 试验。
Muscle Nerve. 2010 Aug;42(2):157-64. doi: 10.1002/mus.21661.
2
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.欧洲神经病学会联合会/周围神经学会关于在小纤维神经病诊断中使用皮肤活检的指南。欧洲神经病学会联合会和周围神经学会联合工作组的报告。
J Peripher Nerv Syst. 2010 Jun;15(2):79-92. doi: 10.1111/j.1529-8027.2010.00269.x.
3
Duloxetine for treating painful neuropathy or chronic pain.度洛西汀用于治疗疼痛性神经病变或慢性疼痛。
Cochrane Database Syst Rev. 2009 Oct 7(4):CD007115. doi: 10.1002/14651858.CD007115.pub2.
4
Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor.随机安慰剂对照双盲临床试验中使用大麻为基础的药物（Sativex）治疗糖尿病性神经痛：抑郁症是一个主要的混杂因素。
Diabetes Care. 2010 Jan;33(1):128-30. doi: 10.2337/dc09-1029. Epub 2009 Oct 6.
5
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.5%利多卡因药用贴剂与普瑞巴林治疗带状疱疹后神经痛和糖尿病性多发性神经病的开放标签、非劣效性两阶段随机对照试验研究
Curr Med Res Opin. 2009 Jul;25(7):1663-76. doi: 10.1185/03007990903047880.
6
Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).1 型糖尿病患者强化胰岛素治疗对心脏自主神经系统功能的影响：糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究（DCCT/EDIC）。
Circulation. 2009 Jun 9;119(22):2886-93. doi: 10.1161/CIRCULATIONAHA.108.837369. Epub 2009 May 26.
7
Advances in the management of diabetic peripheral neuropathy.糖尿病周围神经病变管理的进展
Curr Opin Support Palliat Care. 2009 Jun;3(2):136-43. doi: 10.1097/SPC.0b013e32832b7df5.
8
Quantification of sweat gland innervation: a clinical-pathologic correlation.汗腺神经支配的定量分析：临床与病理的相关性
Neurology. 2009 Apr 28;72(17):1479-86. doi: 10.1212/WNL.0b013e3181a2e8b8.
9
Sudomotor dysfunction is associated with foot ulceration in diabetes.发汗功能障碍与糖尿病足溃疡相关。
Diabet Med. 2009 Mar;26(3):302-5. doi: 10.1111/j.1464-5491.2009.02677.x.
10
The value of skin biopsy with recording of intraepidermal nerve fiber density and quantitative sensory testing in the assessment of small fiber involvement in patients with different causes of polyneuropathy.皮肤活检记录表皮内神经纤维密度及定量感觉测试在评估不同病因所致多发性神经病患者小纤维受累情况中的价值。
J Neurol. 2009 Jul;256(7):1067-75. doi: 10.1007/s00415-009-5065-y. Epub 2009 Mar 1.
Zotero 插件